Teladoc Health, Inc. (TDOC) — SEC Financial Statements & Analysis

Teladoc Health, Inc. (TDOC) is a services-offices & clinics of doctors of medicine company, incorporated in DE. Teladoc Health, Inc. trades on NYSE as: TDOC. Teladoc Health, Inc. (TDOC)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-07-30. Based on that filing, Teladoc Health, Inc. carries a market cap of $1.54B, a P/E ratio of -8.65x, a P/B ratio of 1.17x, a P/S ratio of 0.62x, an enterprise value of $1.76B, and an EV/EBITDA multiple of 10.38x. On profitability, it posts a gross margin of 68.97%, an operating margin of -7.50%, a net margin of -7.13%, a Return on Equity (ROE) of -12.99%, a Return on Assets (ROA) of -6.28%, and a Return on Invested Capital (ROIC) of -10.78%. Per share, it reports EPS of $-0.98, diluted EPS of $-0.98, free cash flow per share of $1.40, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of -2.08% year-over-year, net income growth of -14.45% year-over-year, and EPS growth of -16.86% year-over-year. On the balance sheet, it maintains a current ratio of 0.83x, a quick ratio of 0.72x, working capital of $-233.37M, a debt-to-equity ratio of 1.11x, a debt ratio of 0.53, an interest coverage ratio of -9.36x, free cash flow of $253.70M (TTM), and net debt of $222.35M. Figures sourced from SEC EDGAR.

Market Cap

$1.54B

P/E TTM

-8.65x

EPS TTM

$-0.98

P/B TTM

1.17x

ROE TTM

-12.99%

ROA TTM

-6.28%

Debt To Equity

1.11x

Free Cash Flow TTM

$253.70M

Net Revenue TTM Growth 1Y

-2.08%

Data as of 2026-06-30 · Source: SEC EDGAR